Gene · 64072
Papers1,428
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,428
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotypic and Allelic Frequencies of GJB2 Variants and Features of Hearing Phenotypes in the Chinese Population of the Dongfeng-Tongji Cohort. | Genes (Basel) | 2023 | 38002950 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors. | Nat Commun | 2023 | 37980418 | PubTator, text mining | PubMed |
| Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? | J Clin Med | 2023 | 37959410 | PubTator, text mining | PubMed |
| VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy. | Cancer Cell Int | 2023 | 37936192 | PubTator, text mining | PubMed |
| Recent advances in genetic etiology of non-syndromic deafness in children. | Front Neurosci | 2023 | 37928735 | PubTator, text mining | PubMed |
| Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 | 37910143 | PubTator, text mining | PubMed |
| Nanomechanics of wild-type and mutant dimers of the tip-link protein protocadherin 15. | bioRxiv | 2023 | 37905108 | PubTator, text mining | PubMed |
| Case report: Identification of potential prognosis-related LAG3 overexpression and DICER1 mutation in pituitary carcinoma: two cases. | Front Neurosci | 2023 | 37901430 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
| Combined Presence in Heterozygosis of Two Variant Usher Syndrome Genes in Two Siblings Affected by Isolated Profound Age-Related Hearing Loss. | Biomedicines | 2023 | 37893031 | PubTator, text mining | PubMed |
| The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies. | Biomedicines | 2023 | 37893030 | PubTator, text mining | PubMed |
| Screening of genes interacting with high myopia and neuropsychiatric disorders. | Sci Rep | 2023 | 37884635 | PubTator, text mining | PubMed |
| Functional enrichment analysis of mutated genes in children with hyperthyroidism. | Front Endocrinol (Lausanne) | 2023 | 37876543 | PubTator, text mining | PubMed |
| Next-generation sequencing improves precision medicine in hearing loss. | Front Genet | 2023 | 37811145 | PubTator, text mining | PubMed |
| Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study. | Genome Med | 2023 | 37805537 | PubTator, text mining | PubMed |
| End binding-3 inhibitor activates regenerative program in age-related macular degeneration. | Cell Rep Med | 2023 | 37794584 | PubTator, text mining | PubMed |
| Novel Variant in CEP250 Causes Protein Mislocalization and Leads to Nonsyndromic Autosomal Recessive Type of Progressive Hearing Loss. | Cells | 2023 | 37759551 | PubTator, text mining | PubMed |
| The association between prenatal famine, DNA methylation and mental disorders: a systematic review and meta-analysis. | Clin Epigenetics | 2023 | 37716973 | PubTator, text mining | PubMed |
| Finding a window for gene therapy for hereditary deafness. | Proc Natl Acad Sci U S A | 2023 | 37703299 | PubTator, text mining | PubMed |
| Impact of inner ear malformation and cochlear nerve deficiency on the development of auditory-language network in children with profound sensorineural hearing loss. | Elife | 2023 | 37697742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64072/papers?page=7